AI assistant
Sending…
Innoviva, Inc. — Director's Dealing 2010
Dec 3, 2010
32090_dirs_2010-12-03_9ac8b3b0-e61f-4de9-819d-496c6f33f2ef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2010-12-01
Reporting Person: Brinkley David L (Head of Business Dev.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-12-01 | Common Stock | M | 15275 | $3.1 | Acquired | 58359 | Direct |
| 2010-12-01 | Common Stock | S | 20000 | $25.07 | Disposed | 38359 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-12-01 | Stock Option (Right to Buy) | $3.10 | M | 15275 | Disposed | 2013-01-24 | Common Stock (15275) | Direct |
Footnotes
F1: Immediately exercisable.
More from Innoviva, Inc.
Board/Management Information
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 4
Major Shareholding Notification
2026
Mar 27
Earnings Release
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2025
Nov 24